Procurement Summary
Country: USA
Summary: Capdependent Endonuclease Inhibitors Cenis Nhrc
Deadline: 25 May 2026
Posting Date: 16 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141394317
Document Ref. No.: N0018926QB059
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
The preclinical development of Cap-dependent endonuclease inhibitors (CENi), a class of small molecules, as broad-spectrum antiviral therapeutics. The scope of this project includes all activities required to select lead CENi candidates, including in vitro and in vivo efficacy studies and characterization and optimization of lead compounds. This includes Research Support expertise regarding the preclinical development of cap-dependent endonuclease inhibitors (CENis) with viruses that require biosafety level 4 (BSL-4) containment to support the Naval Medical Research Command in Fort Detrick, MD. This work will be performed over a 36-month period.
Notice ID: n0018926qb059
Department/Ind. Agency: dept of defense
Sub-tier: dept of the navy
Office: navsup flt log ctr norfolk
Product Service Code: an42 - health r&d services; health care - other; applied research
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Inactive Dates: jun 09, 2026
Inactive Policy: 15 days after date offers due
Documents
Tender Notice
Documents.zip